The biobank (biospecimen/ biorepository/biopreservation) market for equipment and media is anticipated to show a sharp rise in Asia and RoW.
(PRWEB) February 19, 2013
Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. Cryopreservation, vitrification and hypothermic storage are the common biopreservation procedures used widely in laboratory and clinical settings. The increase in cell-banking systems like adult stem cell banking, tissue banking, and umbilical cord blood banking has led to an increase in demand for the concept of biopreservation. Antibodies and proteins obtained from high-yielding cell-lines are required by biotech and pharmaceutical companies for research, diagnostic or clinical purposes. These high-yielding cell lines need to be preserved to give optimum yield, viability and productivity.
The global biobank (biospecimen/ biorepository/biopreservation) market for equipment and media is broadly categorized into two segments, namely, biopreservation media market, and biopreservation equipment market. These markets are dominated by the U.S. in 2012, followed by Europe, Asia, and Rest of the World (RoW), due to government investments and tremendous research activities in this geographical region.
The biobank (biospecimen/ biorepository/biopreservation) market for equipment and media is anticipated to show a sharp rise in Asia and RoW. This rise is due to increasing investments by government and non-government organizations. Biotechnology and pharmaceutical companies are also making investments for cell-based therapy research across the globe. There is increased awareness and adoption of cord blood banking among the people. Biobanks are getting established rapidly and research for treatment of cell and tissue disorders is on the rise. The main application areas driving the biobank (biospecimen/ biorepository/biopreservation) market for equipment and media are advances in regenerative medicine, biobanking and drug discovery. Despite restraints such as financial, ethical, regulatory and reimbursement issues, the biopreservation market is expected to grow in the next five years.
The global biobank (biospecimen/ biorepository/biopreservation) market for equipment and media witnesses high competitive intensity. Segment rivalry is high, as there are a few big firms and many small firms with similar product offerings. The firms operating in the market fight to garner market share, leading to frequent price wars, advertising battles, incessant launch of new products, and increased customer services & warranties.
The global biopreservation media market is dominated by home-brew media solutions, which account for nearly 71% of the market. Apart from home-brew media solutions, the major players operating in the biopreservation media market include Organ Recovery Systems, Teva Pharmaceuticals, and Genzyme. The global biopreservation equipment market has many well-established as well as local players dominating the industry market. Some of the major players are Thermofisher Scientific, Taylor-Wharton, and VWR International.
The research report categorizes the global biobank (biospecimen/ biorepository/biopreservation) market for equipment and media into two segments: biopreservation media market and biopreservation equipment market. Both of these markets are broken down into segments and sub-segments, providing exhaustive value-volume analysis for the years (2010, 2011 and 2012) as well as forecast up to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia and Rest of the World (RoW)) to provide in-depth information on the global scenario.
Leading players featured in this publication include Biopreservation Media Manufacturers, Atlanta Biologicals, Inc., Biolife Solutions, Inc., Bioniche Pharma Usa Llc, Cell & Tissue Systems, Inc., Essential Pharmaceuticals, Llc, Genzyme Corporation, Lifeline Scientific, Inc. (Organ Recovery Systems), Preservation Solution, Inc., SigmaAldrich Corporation, Teva Pharmaceutical Industries Limited, WakChemie Medical Gmbh, Biopreservation Equipment Manufacturers, Biocision, Llc, Biogenics, Core Dynamics, Ltd., Custom Biogenic Systems, Inc., Panasonic Biomedical Sales Europe B.V., Princeton Cryotech, Inc., SoLow Environmental Equipment Co., Inc., TaylorWharton Cryogenics, Thermogenesis Corporation, Biopreservation Media And Equipment Manufacturers, Thermo Fisher Scientific, Inc., and Vwr International, Llc.
For more information please visit http://www.researchandmarkets.com/research/wbkpps/global_biobank
Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716